Cluster Headache Clinical Trial
Official title:
Circadian Changes of the Hypothalamic Activity in Patients Suffering From Cluster Headache
| NCT number | NCT04409977 |
| Other study ID # | 2018-02389 |
| Secondary ID | |
| Status | Recruiting |
| Phase | |
| First received | |
| Last updated | |
| Start date | June 26, 2019 |
| Est. completion date | June 30, 2020 |
Cluster headache attacks do not occur randomly throughout the day, but have a clear circadian rhythmicity. The aim of this study is to investigate circadian changes of the brain, the autonomic nervous system and pain processing systems.
| Status | Recruiting |
| Enrollment | 60 |
| Est. completion date | June 30, 2020 |
| Est. primary completion date | June 30, 2020 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 85 Years |
| Eligibility |
Inclusion Criteria: - Diagnosis of cluster headache (CH) may enter the patient group, patients not suffering from CH may enter the control group. - knowledge of the german language suffices to understand the information sheet and consent form - having read, understood and signed the consent form Exclusion Criteria: - Pregnancy - contraindications for the MRI scan (particularly metal splinters, ferromagnetic devices and implants) - claustrophobia - obesity (MRI > 35 kg/m2) - shift working (last night shift must date back more than one week) - jet lag (last travel over more than two time zones must date back more than one week) |
| Country | Name | City | State |
|---|---|---|---|
| Switzerland | University hospital Zurich | Zürich | Zurich |
| Lead Sponsor | Collaborator |
|---|---|
| University of Zurich |
Switzerland,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Circadian rhythmicity of the functional connectivity of the brain | Changes from baseline in functional connectivity of the brain using whole-brain fMRI | Measurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes. | |
| Secondary | Circadian rhythmicity of the pain threshold | Changes from baseline of the pain threshold in the face using quantitative sensory testing (QST) | Measurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes. | |
| Secondary | Circadian changes in the perfusion of the brain. | Changes from baseline in perfusion of the brain using Arterial Spin Labeled MRI Perfusion Imaging and vascular space occupancy sequences | Measurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes. | |
| Secondary | Circadian rhythmicity of the autonomic system | Changes from baseline in the pupillary response (measured using pupillometry) | Measurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes. | |
| Secondary | Circadian rhythmicity of the spectroscopy of the hypothalamus | Changes from baseline in the spectroscopy of the hypothalamus | Measurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes. | |
| Secondary | Circadian rhythmicity of the spectroscopy of the hypothalamus | Changes from baseline in the iron concentration of the brain using quantitative susceptibility mapping | Measurements will be made at noon and at 1 a.m. (+/- 2 hours); we will compare these measurements to identify changes. |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05264714 -
Cluster Headache Treatment With Rimegepant
|
Phase 2 | |
| Completed |
NCT01677026 -
Data Collection on the ATI Neurostimulation System: SPG Stimulation for Cluster Headache
|
||
| Terminated |
NCT00203190 -
A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster Headache
|
Phase 4 | |
| Terminated |
NCT04570475 -
High Dose Vitamin D Plus Multivitamin in the Prevention of Cluster Headache
|
Phase 3 | |
| Completed |
NCT04066023 -
Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches
|
Phase 2/Phase 3 | |
| Withdrawn |
NCT04353505 -
Intra-arterial Sphenopalatine Ganglion Block for Patients With Refractory Headache
|
Phase 1 | |
| Completed |
NCT02019017 -
Botox Injection in Treatment of Cluster Headache
|
Phase 1/Phase 2 | |
| Completed |
NCT05153876 -
An Open Internet-based Survey and Natural Language Processing Project Analysing Written Monologues by Headache Patients
|
||
| Recruiting |
NCT05324748 -
Repeated GON Injections in CCH
|
Phase 3 | |
| Completed |
NCT02782533 -
DBS of the Third Ventricle for Cluster Headache and Obesity
|
N/A | |
| Completed |
NCT04179266 -
Effect of Ketamine Intranasal Spray in Treatment of Chronic Cluster Headache
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04406259 -
Atrioventricular Block and Cluster Headache (SEVA)
|
Phase 4 | |
| Recruiting |
NCT06206772 -
Resting State Functional Connectivity in Cluster Headache
|
||
| Recruiting |
NCT03944876 -
Botulinum Toxin Type A Blockade of the Sphenopalatine Ganglion in Treatment-refractory Chronic Cluster Headache
|
Phase 3 | |
| Not yet recruiting |
NCT05857098 -
Detection of Local Field Potentials in the Ventral Tegmental Area of the Midbrain in Chronic Cluster Headache Patients
|
||
| Recruiting |
NCT02910323 -
The Will Erwin Headache Research Center - Cluster Headache Study
|
||
| Terminated |
NCT00458770 -
Study of Hypothalamic Metabolism in Spontaneous Cluster Headache Attacks
|
N/A | |
| Completed |
NCT00662935 -
Evaluation of Efficacity and Safety of Deep Brain Stimulation (DBS) in Chronic and Treatment-Resistant Cluster Headache(CH)
|
N/A | |
| Active, not recruiting |
NCT03511846 -
Pain Biomarker Study
|
Phase 1 | |
| Completed |
NCT00184587 -
Prophylactic Treatment of Episodic Cluster Headache
|
Phase 2 |